Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2/3 1Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 13OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Papillomavirus Infections 1Neoplasms 1Cancer Survivor 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Vaccines, Synthetic × Clear all
NCT05435209 2023-11-29

Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents

University of Washington

Phase 4 Completed
158 enrolled

Papillomavirus Infections

NCT05149248 2021-12-08

CONDESA

Instituto Nacional de Salud Publica, Mexico

Phase 2/3 Completed
6,000 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT01492582 2021-10-27

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

University of Alabama at Birmingham

Phase 2 Completed
1,499 enrolled 11 charts

Cancer Survivor

NCT00524745 2017-04-14

Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

PATH

Phase NA Completed
903 enrolled 10 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡